NCT03999229View on ClinicalTrials.gov

S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion

PHASE1RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Transfusion Related Complication
Interventions
DRUG

SNO

S-nitrosylating agent (SNO) Inhalation

DRUG

Normal Saline

Normal Saline transfusion

DRUG

Red Blood Cell

Blood transfusion (RBCs)

Trial Locations (1)

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

James Reynolds

OTHER